185 related articles for article (PubMed ID: 8094914)
1. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
[No Abstract] [Full Text] [Related]
2. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
3. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
Isobe M; Ihara A
Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
[No Abstract] [Full Text] [Related]
4. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
[No Abstract] [Full Text] [Related]
5. Immunologic characterization of murine cardiac allograft recipients with long-term graft survival due to anti-VCAM-1 or anti-CD4 monoclonal antibody therapy.
Orosz CG; Bergese SD; Huang EH; Vanbuskirk AM
Transplant Proc; 1995 Feb; 27(1):387-8. PubMed ID: 7533414
[No Abstract] [Full Text] [Related]
6. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
[No Abstract] [Full Text] [Related]
7. Prolongation of hepatic allograft survival with antibodies to ICAM-1 and LFA-1.
Harihara Y; Sakamoto H; Sanjo K; Otsubo O; Watanabe G; Idezuki Y
Transplant Proc; 1994 Aug; 26(4):2258. PubMed ID: 7915063
[No Abstract] [Full Text] [Related]
8. Clonal anergy induction by monoclonal antibodies to CD4, LFA-1, and ICAM-1.
Jendrisak G; Gamero J; Mohanakumar T; Jendrisak M
Transplant Proc; 1993 Feb; 25(1 Pt 1):828-30. PubMed ID: 8094915
[No Abstract] [Full Text] [Related]
9. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
[No Abstract] [Full Text] [Related]
10. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
11. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
[TBL] [Abstract][Full Text] [Related]
12. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
[No Abstract] [Full Text] [Related]
13. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
Stepkowski SM; Tu Y; Condon TP; Bennett CF
Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
[No Abstract] [Full Text] [Related]
14. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
Chen Z; Cobbold S; Waldmann H; Metcalfe S
Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
[No Abstract] [Full Text] [Related]
15. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
[No Abstract] [Full Text] [Related]
16. Microchimerism and graft acceptance: cardiac allograft acceptance following antiadhesion molecules antibody therapy.
Hara MH; Tanigawa M; Matsuzaki M; Onitsuka T; Shibata K; Koga Y; Suzuki H; Yamashita A; Miyamoto M; Li XK; Suzuki S; Amemiya H; Yokoi Y; Iwaya M; Yamaguchi A; Masaki Y; Miyasaka M; Kimura H
Transplant Proc; 1996 Jun; 28(3):1370-1. PubMed ID: 8658699
[No Abstract] [Full Text] [Related]
17. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody to anti-VCAM-1 interferes with murine cardiac allograft rejection.
Pelletier R; Ohye R; Kincade P; Ferguson R; Orosz C
Transplant Proc; 1993 Feb; 25(1 Pt 1):839-41. PubMed ID: 7679845
[No Abstract] [Full Text] [Related]
19. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M
Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
[No Abstract] [Full Text] [Related]
20. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
